NDC 36000-320-01 - Labetalol Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 36000-320
- Requested NDC
- 36000-320-01
- Package NDCs from labels
- 36000-320-01, 36000-320-10
- Manufacturer
- Baxter Healthcare Corporation | CAPLIN STERILES LIMITED
- Effective date
- 2020-07-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LABETALOL - Baxter Healthcare Corporation | CAPLIN STERILES LIMITED | Baxter Healthcare Corporation | CAPLIN STERILES LIMITED | 2020-07-24 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 36000-320-01 | Labetalol Hydrochloride | 4 mL in 1 VIAL | INJECTION, SOLUTION | 4 | 6 | |
| 36000-320-10 | Labetalol Hydrochloride | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 6 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 36000-320-01 | ML - Milliliter | 36000-320 | b34ef2e5-e1d1-4c87-a0d3-882601c81f1a | 1 | 2021-05-05 |
| 36000-320-10 | ML - Milliliter | 36000-320 | 6134708c-3a79-4938-bc35-c888ef71af68 | 1 | 2021-05-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Cardinal Health 107, LLC | d3ca153c-25b2-4506-91bd-bf9d6a4c01fe | 2026-05-19 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Bryant Ranch Prepack | c0c1a162-cd30-4ac9-bc62-407493ed54a5 | 2026-05-11 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Market Basket Effervescent Antacid and Pain Relief | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Demoulas Super Markets, Inc. | e15439c7-0e3c-7752-e053-2995a90a1a40 | 2026-05-11 | Warnings | XF417D3PSL |
| Meijer Effervescent Antacid and Pain Relief | ASPIRIN, ANHYDROUS CITRIC ACID, SODIUM BICARBONATE | Meijer Distribution Inc | 7305972b-aa0f-4daa-e053-2991aa0adfd7 | 2026-05-11 | Warnings | XF417D3PSL |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Proficient Rx LP | 54b75509-824b-4291-818d-71dc1b88915f | 2026-05-01 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Golden State Medical Supply, Inc. | d5ce687f-4a37-d3e6-e053-2995a90aa974 | 2026-04-16 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | A-S Medication Solutions | 371cb135-6a5f-433d-a87d-ab8521c4aa6d | 2026-04-16 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | A-S Medication Solutions | f9af85d3-a5a7-49d6-aff6-1ca2b2d75450 | 2026-04-16 | Warnings, Adverse reactions | 1GEV3BAW9J |
| CLENPIQ | SODIUM PICOSULFATE, MAGNESIUM OXIDE, AND ANHYDROUS CITRIC ACID | Ferring Pharmaceuticals Inc. | e95fff66-4ec0-4001-a727-33e66a5ec7d5 | 2026-04-15 | Warnings, Adverse reactions | XF417D3PSL |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | NorthStar Rx LLC | 5bd81a8a-a480-4c8d-bd4f-3158412e6a73 | 2026-04-13 | Warnings, Adverse reactions | 1GEV3BAW9J |
| LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | REMEDYREPACK INC. | ae5d7b3b-e444-48d3-9d85-9b07319f9374 | 2026-04-10 | Warnings, Adverse reactions | 1GEV3BAW9J |
| LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | Advagen Pharma Ltd | 106a0959-5830-489f-ba60-afd4eb0fac36 | 2026-04-02 | Warnings, Adverse reactions | 1GEV3BAW9J |
| LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | Advagen Pharma Ltd | 1c680447-b43a-4ff1-bc64-2c2174ca1c9a | 2026-04-02 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | A-S Medication Solutions | d4364caf-46c6-4144-9ba5-2c561e4f3a95 | 2026-03-26 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | A-S Medication Solutions | d207396a-068e-4229-88cc-a1a4df7aeff2 | 2026-03-07 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | A-S Medication Solutions | b4a5f170-a400-4986-8c64-f55d0413f0f6 | 2026-03-07 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | bf84ebae-3c91-4448-b1db-8e5ed3053866 | 2026-03-05 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Major Pharmaceuticals | 35b5fd32-581d-427b-9a13-b7a02846d21d | 2026-03-03 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Civica, Inc. | d7c53b1c-b6a5-482a-a7c8-7425d9cd9ef8 | 2026-03-03 | Warnings, Adverse reactions | 896771 1GEV3BAW9J |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Zydus Pharmaceuticals USA Inc. | 5942a5a8-c3c1-4ecb-921e-9bc92393bdf8 | 2026-03-02 | Warnings, Adverse reactions | 1GEV3BAW9J |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.